Zinzino group revenue increased with a total of 15%, compared with the previous year.
GOTHENBURG, Sweden, Feb. 5, 2024 /PRNewswire/ — The revenue in January for Zinzino’s sales markets increased by 17% and amounted to SEK 140.2 (120.3) million. Faun Pharma’s external sales decreased by 11% and amounted to SEK 8.1 (9.1) million. Overall, the Group increased revenues by 15% to SEK 148.3 (129.4) million compared with the previous year.
Revenues were distributed as follows:
|
Regions, mSEK |
24-Jan |
23-Jan |
Change |
|
The Nordics |
22.6 |
23.4 |
-3 % |
|
Central Europe |
41,0 |
28.5 |
44 % |
|
East Europe |
31.8 |
32.8 |
-3 % |
|
South & West Europe |
21.8 |
15.9 |
37 % |
|
The Baltics |
8,0 |
7.4 |
8 % |
|
North America |
10.1 |
6.3 |
60 % |
|
Asia-Pacific |
3.9 |
4.6 |
-15 % |
|
Africa |
1,0 |
1.4 |
-29 % |
|
Zinzino |
140.2 |
120.3 |
17 % |
|
Faun Pharma |
8.1 |
9.1 |
-11 % |
|
Zinzino Group |
148.3 |
129.4 |
15 % |
Countries in regions:
-The Nordics: Denmark, Faroe Island, Finland, Iceland, Norway, Sweden
–Central Europe: Austria, Germany, Switzerland
–East Europe: Czech Republic, Slovakia, Hungary, Poland, Romania
-South & West Europe: Cyprus, France, Greece, Italy, Luxembourg, Malta, Netherlands, Slovenia, Spain, United Kingdom, Belgium, Ireland, Turkey
-The Baltics: Estonia, Latvia, Lithuania
–North America: Canada, USA, Mexico
–Asia-Pacific: Australia, Hong Kong, India, Malaysia, Singapore, Taiwan, Thailand
–Africa: South Africa
For more information:
Dag Bergheim Pettersen CEO Zinzino +47 (0) 932 25 700, zinzino.com
Pictures for publication free of charge: marketing@zinzino.com
Certified Adviser: Carnegie Investment Bank AB (publ)
The following files are available for download:
|
https://mb.cision.com/Public/10976/3922690/9444cbaf7b346cd0.pdf |
2401 Pressrelease Salesreport EN |
View original content:https://www.prnewswire.co.uk/news-releases/zinzino-ab-publ-preliminary-sales-report-january-2024-302053390.html
Disclaimer: The above press release comes to you under an arrangement with PR Newswire. TheNewsThisWeek.co.uk takes no editorial responsibility for the same.